Guy Van Meter

Guy Van Meter is the current Chief Business Officer at Adimab. Guy has also worked for companies such as Pfizer, Dyax Corp, and Alkermes, Inc. In their previous positions, they have been responsible for business development, negotiating agreements, and conducting research. Guy has a wealth of experience in the field and is considered an expert in their field.

They work with Eric Krauland - President & Chief Scientific Officer, Kristin Rookey - Senior Director, Strategic Alliances, and Anadys Pharmaceuticals - Principal Scientist, Dyax. Guy Van Meter reports to Philip Chase, CEO.